Skip to content

Clinical Efficacy of Cephalic Acupressure in Managing Mild Alzheimer's Disease with Medullary Sea Insufficiency

Clinical Efficacy of Cephalic Acupressure in Managing Mild Alzheimer's Disease with Medullary Sea Insufficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001321
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

experimental group:Routine treatment and care and acupressure points on the head

Sponsors

Shuguang Hosptial affiliated to Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Meets diagnostic criteria for mild Alzheimer's disease as defined by a Clinical Dementia Rating (CDR) score of 1.The Clinical Dementia Rating Scale (CDR) is widely regarded as the gold standard for the clinical grading of Alzheimer's disease (AD) dementia. A score of 0.0 indicates normal cognitive function 0.5 indicates suspected dementia 1.0 indicates mild dementia 2.0 indicates moderate dementia and 3.0 indicates severe dementia . Secondly the subject fulfills the diagnostic criteria of the medullary insufficiency type of Chinese medicine.Thirdly the subject is over the age of 60.Fourthly the subject was able to cooperate independently to complete the scale.Fifthly the subject voluntarily accepted clinical observation and gave informed consent.

Exclusion criteria

Exclusion criteria: The following criteria are indicative of the diagnosis of organic Alzheimer's disease as indicated by brain CT: The presence of disorders of consciousness or mental illness The presence of serious coagulation disorders The presence of malignant tumors The presence of serious infections The presence of serious diseases including digestive system diseases liver and kidney diseases cardiovascular diseases and cerebrovascular diseases

Design outcomes

Primary

MeasureTime frame
ADL (activity of daily living);

Secondary

MeasureTime frame
HAMA;Chinese Medicine Symptom Score (CMS);Montreal cognitive assessment;ADAS-cog;HAMD;MMSE;

Countries

China

Contacts

Public ContactZhou Weina

Shanghai Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

13917592088@163.com13917592088

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026